CMS: Theranos’ Practices Pose ‘Immediate Jeopardy’ To Patient Health
U.S. regulators found serious shortcomings at Theranos' lab in the latest in a series of setbacks for the blood testing startup. Deficiencies at Newark, California, lab “pose immediate jeopardy to patient health and safety,” the Centers for Medicare & Medicaid Services said in a letter to the company released Wednesday that demanded immediate changes at the lab and threatened the closely held company with sanctions.
Reuters:
Theranos Lab Poses 'Jeopardy To Patient Health': Regulator
USA Today:
Theranos Lab Poses 'Immediate Jeopardy' To Patients, Say Regulators
The Associated Press:
Regulators Warn Testing Startup Theranos Over Lab Conditions
The Wall Street Journal:
Theranos Lab Practices Pose Risk to Patient Health, Regulators Say
The New York Times:
Theranos Lab May Pose Threat To Patient Safety, Regulator Says
Bloomberg:
Theranos Lab Faults Jeopardized Patient Health, U.S. Says